No cases of allergic reactions recorded during Pfizer's COVID-19 vaccine trial - company executive

(Reuters) - There were no cases of severe allergic reactions to Pfizer Inc and partner BioNTech SE's COVID-19 vaccine candidate during clinical trials, a Pfizer executive said at a regulatory conference on Friday. A late-stage trial testing the potential vaccine excluded participants who had a prior history of severe allergic reactions to any vaccine or to the constituents of Pfizer/BioNTech vaccine, said Dr. William Gruber, Pfizer's senior vice president of vaccine clinical research and development.

Reuters December 12, 2020 03:10:13 IST
No cases of allergic reactions recorded during Pfizer's COVID-19 vaccine trial - company executive

COVID-19 vaccine trial - company executive" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/12/2020-12-11T203521Z_1_LYNXMPEGBA1GW_RTROPTP_2_HEALTH-CORONAVIRUS-VACCINE.jpg" alt="No cases of allergic reactions recorded during Pfizers COVID19 vaccine trial company executive" width="300" height="225" />

(Reuters) - There were no cases of severe allergic reactions to Pfizer Inc and partner BioNTech SE's COVID-19 vaccine candidate during clinical trials, a Pfizer executive said at a regulatory conference on Friday.

A late-stage trial testing the potential vaccine excluded participants who had a prior history of severe allergic reactions to any vaccine or to the constituents of Pfizer/BioNTech vaccine, said Dr. William Gruber, Pfizer's senior vice president of vaccine clinical research and development.

"We've not had any anaphylactic episodes related to the vaccine," Gruber said during a panel meeting of independent advisers to the U.S. Centers for Disease Control and Prevention.

The trial included about 6,000 participants respectively in both the vaccine and placebo groups with a history of a range of allergic conditions like pollen allergy, food allergy, all the way up to anaphylaxis, Pfizer executive Susan Mather said.

Anaphylaxis is an overreaction by the body's immune system that could sometimes be life-threatening.

The comments follow British medicine regulator's advice that people with a history of significant allergic reactions do not get the Pfizer-BioNTech's vaccine after two people reported adverse effects.

The U.S. Food and Drug Administration is expected to issue an emergency use authorization for the two-dose vaccine as soon as Friday, according to the New York Times.

Once authorized, the first Americans could be immunized as soon as Monday or Tuesday, with healthcare workers expected to be among the first in line.

(Reporting by Manojna Maddipatla in Bengaluru)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Moderna raises 2021 vaccine output forecast to at least 600 million doses
World

Moderna raises 2021 vaccine output forecast to at least 600 million doses

(Reuters) -Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine. The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said

On thin ice? Poles get creative to skate round coronavirus rules
World

On thin ice? Poles get creative to skate round coronavirus rules

WARSAW (Reuters) - A skating rink owner in the Polish city of Szczecin believes he has found a way to keep his business open despite coronavirus restrictions - operate as a flower shop instead. His plan is simple - the customer has to purchase access to the flower "warehouse", then chooses from a box of flowers in the middle of the rink. "You can jump, crawl or go on all fours ..

Yemeni boy, ravaged by hunger, weighs 7 kg
World

Yemeni boy, ravaged by hunger, weighs 7 kg

By Reuters Staff SANAA (Reuters) - Paralysed and severely malnourished, seven-year-old Faid Samim lies curled up on a hospital bed in the Yemeni capital Sanaa, having barely survived the journey there.  "He was almost gone when he arrived but thank God we were able to do what was necessary and he started improving. He is suffering from CP (cerebral palsy) and severe malnutrition," said Rageh Mohammed, the supervising doctor of the Al-Sabeen hospital's malnutrition ward.